Variant report

Variant	esv3316045
Chromosome Location	chr17:46615786-46617226
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:17)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:17 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	FOS	chr17:46616576-46616775	MCF10A-Er-Src	breast:	n/a	chr17:46616632-46616639 chr17:46616632-46616640 chr17:46616632-46616640 chr17:46616633-46616644
2	MAFK	chr17:46616491-46616808	IMR90	lung:	n/a	n/a
3	POLR2A	chr17:46616659-46616976	K562	blood:	n/a	n/a
4	POLR2A	chr17:46616344-46617223	U87	brain:	n/a	n/a
5	POLR2A	chr17:46616566-46616947	IMR90	lung:	n/a	n/a
6	POLR2A	chr17:46616673-46616793	MCF10A-Er-Src	breast:	n/a	n/a
7	POLR2A	chr17:46616508-46616944	U87	brain:	n/a	n/a
8	POLR2A	chr17:46617169-46618159	K562	blood:	n/a	n/a
9	POLR2A	chr17:46616661-46616865	ProgFib	skin:	n/a	n/a
10	POLR2A	chr17:46616724-46616875	Gliobla	brain:	n/a	n/a
11	POLR2A	chr17:46617177-46620098	PANC-1	pancreas:	n/a	n/a
12	POLR2A	chr17:46616350-46617179	U87	brain:	n/a	n/a
13	POLR2A	chr17:46616973-46622292	K562	blood:	n/a	n/a
14	POLR2A	chr17:46616545-46629919	PANC-1	pancreas:	n/a	n/a
15	RAD21	chr17:46616581-46616910	IMR90	lung:	n/a	n/a
16	RCOR1	chr17:46616288-46617988	IMR90	lung:	n/a	n/a
17	ZNF384	chr17:46616570-46616627	K562	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:46616394-46616444	U87	brain:	n/a
2	chr17:46616394-46616444	AG10803	skin:	n/a
3	chr17:46616394-46616444	Jurkat	blood:	n/a
4	chr17:46616394-46616444	PrEC	prostate:	n/a
5	chr17:46616394-46616444	HMEC	breast:	n/a
6	chr17:46616394-46616444	AoSMC	blood vessel:	n/a
7	chr17:46616394-46616444	AG04450	lung:	fetal
8	chr17:46616394-46616444	SK-N-SH_RA	brain:	n/a
9	chr17:46616394-46616444	GM19239	blood:	n/a
10	chr17:46616394-46616444	GM12878	blood:	n/a
11	chr17:46616394-46616444	GM06990	blood:	n/a
12	chr17:46616394-46616444	HCM	heart:	n/a
13	chr17:46616394-46616444	H1-hESC	embryonic stem cell:	embryo
14	chr17:46616394-46616444	RPTEC	kidney:	n/a
15	chr17:46616394-46616444	IMR90	lung:	fetal
16	chr17:46616394-46616444	HL-60	blood:	n/a
17	chr17:46616394-46616444	GM12892	blood:	n/a
18	chr17:46616394-46616444	HRCEpiC	kidney:	n/a
19	chr17:46616394-46616444	BE2_C	brain:	n/a
20	chr17:46616394-46616444	AG04449	skin:	fetal
21	chr17:46616394-46616444	GM12891	blood:	n/a
22	chr17:46616394-46616444	ovcar-3	ovarian:	n/a
23	chr17:46616394-46616444	CMK	blood:	n/a
24	chr17:46616394-46616444	Hela-S3	cervix:	n/a
25	chr17:46616394-46616444	HAEpiC	amniotic membrane:	n/a
26	chr17:46616394-46616444	HCT-116	colon:	n/a
27	chr17:46616394-46616444	SK-N-SH	brain:	n/a
28	chr17:46616394-46616444	A549	lung:	n/a
29	chr17:46616394-46616444	LNCaP	prostate:	n/a
30	chr17:46616394-46616444	MCF-7	breast:	n/a
31	chr17:46616394-46616444	MCF10A-Er-Src	breast:	n/a
32	chr17:46616394-46616444	BJ	skin:	n/a
33	chr17:46616394-46616444	NHDF-neo	bronchial:	n/a
34	chr17:46616394-46616444	Caco-2	colon:	n/a
35	chr17:46616394-46616444	HIPEpiC	eye:	n/a
36	chr17:46616394-46616444	NB4	blood:	n/a
37	chr17:46616394-46616444	NHBE	bronchial:	n/a
38	chr17:46616394-46616444	HRPEpiC	eye:	n/a
39	chr17:46616394-46616444	AG09319	gingival:	n/a
40	chr17:46616394-46616444	SK-N-MC	brain:	n/a
41	chr17:46616394-46616444	NH-A	brain:	n/a
42	chr17:46616394-46616444	SAEC	small airway:	n/a
43	chr17:46616394-46616444	HEK293	kidney:	embryo
44	chr17:46616394-46616444	HRE	kidney:	n/a
45	chr17:46616394-46616444	ECC-1	luminal epithelium:	n/a
46	chr17:46616394-46616444	SKMC	muscle:	n/a
47	chr17:46616394-46616444	NT2-D1	testis:	n/a
48	chr17:46616394-46616444	T-47D	breast:	n/a
49	chr17:46616394-46616444	HEEpiC	esophagus:	n/a
50	chr17:46616394-46616444	ProgFib	skin:	n/a

No data

Variant related genes	Relation type
HOXB-AS1	TF binding region
HOXB-AS1	CpG island

Extended variants
information (count: 53 )
Associated
traits (count: 117 )

Variant overlapped rSNPs/rCNVs (count:53 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs200474311	chr17:46615804-46615805	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs537354789	chr17:46615808-46615809	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs34755790	chr17:46615809-46615810	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs371161236	chr17:46615810-46615811	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs570373823	chr17:46615856-46615857	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs145663483	chr17:46615862-46615863	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs370463814	chr17:46615863-46615864	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs71144504	chr17:46615869-46615870	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs539444856	chr17:46615901-46615902	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs11655054	chr17:46615955-46615956	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs9893775	chr17:46616008-46616009	Weak transcription Enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs566598919	chr17:46616029-46616030	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs377449786	chr17:46616042-46616043	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs535174151	chr17:46616151-46616152	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs369865933	chr17:46616171-46616172	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs56173928	chr17:46616200-46616201	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs555543403	chr17:46616221-46616222	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs6504339	chr17:46616244-46616245	Weak transcription Enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs544518429	chr17:46616276-46616277	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs558458652	chr17:46616336-46616337	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs578177073	chr17:46616348-46616349	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs567924323	chr17:46616362-46616363	Weak transcription Enhancers Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs540664299	chr17:46616438-46616439	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs538542873	chr17:46616446-46616447	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs183464399	chr17:46616447-46616448	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs556927070	chr17:46616448-46616449	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs529412466	chr17:46616476-46616477	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs375427668	chr17:46616480-46616481	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs145048294	chr17:46616496-46616497	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs367954090	chr17:46616528-46616529	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs530698833	chr17:46616570-46616571	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs550478024	chr17:46616583-46616584	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs570755858	chr17:46616588-46616589	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs79736374	chr17:46616600-46616601	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs550358541	chr17:46616605-46616606	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs546618636	chr17:46616616-46616617	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs59537628	chr17:46616617-46616618	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs201115223	chr17:46616618-46616619	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs566298102	chr17:46616630-46616631	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs9894600	chr17:46616655-46616656	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs555009255	chr17:46616715-46616716	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs187792171	chr17:46616752-46616753	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs569392745	chr17:46616767-46616768	Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs138822909	chr17:46616806-46616807	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs117644941	chr17:46616887-46616888	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs578229059	chr17:46616901-46616902	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs540526956	chr17:46616992-46616993	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs6504340	chr17:46617019-46617020	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance disease
49	rs574050833	chr17:46617077-46617078	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs12603976	chr17:46617163-46617164	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:117)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Breast cancer	17603634	CNVD
Follicular lymphoma	20505157	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	20953835	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
TAR Syndrome	17847015	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17850661	CNVD
Breast cancer	19261255	CNVD
Lung cancer	16773561	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Basal-like breast cancer	18066063	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Hereditary breast	19566914	CNVD
Ovarian cancer	19047089	CNVD
Ovarian cancer	19566914	CNVD
Triple-negative breast cancer	18950515	CNVD
Breast cancer	16846527	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	21251322	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	16397240	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Non-syndromic sensorineural hearing loss	21084979	CNVD
Autism	22817714	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Frontotemporal lobar degeneration	19640594	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Breast cancer	21509527	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:68 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:46610200-46618400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr17:46612200-46616400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr17:46613200-46615800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr17:46614200-46616200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
5	chr17:46614800-46616800	Strong transcription	Fetal Stomach	stomach
6	chr17:46614800-46618400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr17:46615000-46616200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
8	chr17:46615000-46616200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr17:46615000-46616200	Weak transcription	HSMM	muscle
10	chr17:46615000-46616200	Weak transcription	HSMMtube	muscle
11	chr17:46615000-46616200	Weak transcription	NH-A	brain
12	chr17:46615200-46616200	Weak transcription	Muscle Satellite Cultured Cells	--
13	chr17:46615200-46616200	Weak transcription	NHLF	lung
14	chr17:46615200-46616600	Weak transcription	K562	blood
15	chr17:46615200-46618400	Weak transcription	Fetal Muscle Trunk	muscle
16	chr17:46615400-46619600	Weak transcription	A549	lung
17	chr17:46615600-46616000	Weak transcription	NHDF-Ad	bronchial
18	chr17:46615800-46618000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr17:46616000-46618400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr17:46616000-46618400	Enhancers	NHDF-Ad	bronchial
21	chr17:46616200-46616400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
22	chr17:46616200-46616400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr17:46616200-46616600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr17:46616200-46617000	Enhancers	NH-A	brain
25	chr17:46616200-46617200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr17:46616200-46617200	Enhancers	HSMM	muscle
27	chr17:46616200-46617400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr17:46616200-46617400	Enhancers	NHLF	lung
29	chr17:46616200-46617800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr17:46616200-46618000	Enhancers	HSMMtube	muscle
31	chr17:46616200-46618200	Enhancers	Muscle Satellite Cultured Cells	--
32	chr17:46616200-46618400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr17:46616400-46616600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
34	chr17:46616400-46616600	Enhancers	Placenta Amnion	Placenta Amnion
35	chr17:46616400-46616800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr17:46616400-46617000	Bivalent Enhancer	Osteobl	bone
37	chr17:46616400-46617200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr17:46616400-46617200	Enhancers	Fetal Kidney	kidney
39	chr17:46616600-46616800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr17:46616600-46617000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr17:46616600-46618000	Enhancers	K562	blood
42	chr17:46616600-46618400	Weak transcription	Placenta Amnion	Placenta Amnion
43	chr17:46616600-46618400	Enhancers	NHEK	skin
44	chr17:46616800-46617000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr17:46616800-46617000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr17:46616800-46617000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
47	chr17:46616800-46617400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
48	chr17:46616800-46617400	Enhancers	Primary T helper cells PMA-I stimulated	--
49	chr17:46616800-46617600	Enhancers	Primary T helper naive cells from peripheral blood	blood
50	chr17:46616800-46617800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links